CXCR3 is a receptor for CXCL9, CXCL10, and CXCL11, which are INF-γ inducible and thus associated with inflammatory disorders, including atherosclerosis.[6] It has been suggested that CXCR3 has integral roles in the recruitment of proinflammatory cells during plaque formation, thereby promoting atherogenesis,[9] however its potential role in the progression of plaque leading to an advanced lesion (i.e., a plaque to cause an acute thromboembolic event or Type V and VI lesions [33]) remains obscure. The gene discussed is CXCL9; the disease is atherosclerosis.